Brain oncology research seeks to understand how cancer begins in the brain, why some tumors grow and spread quickly whilst others remain dormant, and how best to treat these tumors. Research in this field generally involves studying different types of brain tumors and how they can be treated – this includes examining current treatments and looking for new and improved therapies to help increasing survival rates. Brain tumor research has increased significantly in recent years thanks to advances in medical technology and imaging techniques - such as Magnetic Resonance Imaging (MRI) scans. MRI scans enable physicians to see detailed real-time images of brain structures, examine the location and shape of tumors, and measure the effectiveness of medication and treatment. Another extremely important area of research in this field focuses on developing new approaches to detect and treat brain tumors. With this in mind, scientists are looking into the use of gene therapy to target malignant brain tumors with the aim of destroying them without damaging surrounding healthy tissue. Additionally, scientists are working on personalizing therapy plans that are tailored to each patient's tumor type, allowing for more effective treatments. Furthermore, research is taking place to develop innovative immunotherapies, which take advantage of the body’s natural defense mechanisms to target and destroy cancer cells. This involves utilizing the body's own immune system to identify and attack cancerous cells, and thus, reduce the risk of toxic side effects. In recent years, brain oncology researchers have made great strides in improving our understanding of brain tumors and greatly advancing treatment options. As the field of research continues to evolve,scientists and physicians hope to eventually be able to identify key molecular pathways of tumors, evaluate treatment responses, and develop methods that can ensure the best possible outcomes for patients.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom